Cambridge, Massachusetts
United States
100
2026-03-19
The entities that hold a legal rights for patent applications filed by inventor Masse Craig E.:
Craig E. Masse from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:
PYRROLO-PYRIDAZINE INHIBITORS OF JAK2
#2 | 2026-03-19TYK2 INHIBITORS AND USES THEREOF
#3 | 2025-10-23TYK2 INHIBITORS AND USES THEREOF
#4 | 2025-06-26TYK2 INHIBITOR SYNTHESIS AND INTERMEDIATES THEREOF
#5 | 2024-11-07FORMS AND COMPOSITIONS OF A JAK2 INHIBITOR
#6 | 2024-08-016-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS
#7 | 2024-04-11HETEROCYCLIC AMIDE AND UREA COMPOUNDS AS JAK2 INHIBITORS
#8 | 2023-12-07TYK2 INHIBITORS AND USES THEREOF
#9 | 2023-08-246-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
#10 | 2023-06-016-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
#11 | 2023-05-11Forms and compositions of inhibitors of JAK2
#12 | 2023-04-13Substituted pyrazolo[5′,1′:2,3]pyrimido[5,4-b][1,4]oxazines as TYK2 inhibitors
#13 | 2023-03-306-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
#14 | 2023-03-09TYK2 INHIBITORS AND USES THEREOF
#15 | 2023-02-23TYK2 INHIBITORS AND USES THEREOF
#16 | 2022-12-296-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
#17 | 2022-11-10TYK2 INHIBITORS AND USES THEREOF
#18 | 2022-04-07TYK2 inhibitors and uses thereof
#19 | 2022-03-10TYK2 INHIBITORS AND USES THEREOF
#20 | 2022-03-10TYK2 INHIBITORS AND USES THEREOF
#21 | 2021-08-05TYK2 INHIBITORS AND USES THEREOF
#22 | 2021-07-29TYK2 inhibitors and uses thereof
#23 | 2021-04-01TYK2 inhibitors and uses thereof
#24 | 2021-02-18TYK2 inhibitors and uses thereof
#25 | 2020-07-23TYK2 inhibitors and uses thereof
#26 | 2020-06-04TYK2 inhibitors and uses thereof
#27 | 2020-04-30Substituted pyrazolo[1,5-a]pyrimidines as TYK2 inhibitors
#28 | 2020-04-02ACC INHIBITORS AND USES THEREOF
#29 | 2019-11-07TYK2 inhibitors, uses, and methods for production thereof
#30 | 2019-09-19TYK2 inhibitors and uses thereof
#31 | 2019-08-22TYK2 inhibitors and uses thereof
#32 | 2019-08-15TYK2 inhibitors and uses thereof
#33 | 2019-08-15TYK2 inhibitors and uses thereof
#34 | 2019-08-08TYK2 inhibitors and uses thereof
#35 | 2019-08-08TYK2 inhibitors and uses thereof
#36 | 2019-08-08TYK2 inhibitors and uses thereof
#37 | 2019-01-31TYK2 inhibitors and uses thereof
#38 | 2019-01-17ACC inhibitors and uses thereof
#39 | 2018-12-13TYK2 inhibitors and uses thereof
#40 | 2018-09-13TYK2 inhibitors, uses, and methods for production thereof
#41 | 2018-06-07TYK2 inhibitors and uses thereof
#42 | 2018-05-17TYK2 inhibitors and uses thereof
#43 | 2017-10-26TYK2 inhibitors and uses thereof
#44 | 2017-08-31TYK2 inhibitors and uses thereof
#45 | 2017-03-09TYK2 inhibitors and uses thereof
#46 | 2017-02-09IRAK INHIBITORS AND USES THEREOF
#47 | 2016-10-13ACC inhibitors and uses thereof
#48 | 2016-10-13TYK2 inhibitors and uses thereof
#49 | 2016-10-13IRAK INHIBITORS AND USES THEREOF
#50 | 2016-09-01TYK2 INHIBITORS AND USES THEREOF
#51 | 2016-07-07IRAK INHIBITORS AND USES THEREOF
#52 | 2016-06-30ACC inhibitors and uses thereof
#53 | 2016-06-30ACC inhibitors and uses thereof
#54 | 2016-04-21ACC inhibitors and uses thereof
#55 | 2016-04-21Bicyclic compounds as ACC inhibitors and uses thereof
#56 | 2016-03-10IRAK inhibitors and uses thereof
#57 | 2016-02-04DEUTERATED 2-AMINO-3-HYDROXYPROPANOIC ACID DERIVATIVES
#58 | 2016-01-07IRAK INHIBITORS AND USES THEREOF
#59 | 2015-12-24Derivatives of pyrazole-substituted amino-heteroaryl compounds
#60 | 2015-11-19IRAK INHIBITORS AND USES THEREOF
#61 | 2015-09-24TYK2 inhibitors and uses thereof
#62 | 2015-07-23ACC inhibitors and uses thereof
#63 | 2015-04-09Synthesis of deuterated morpholine derivatives
#64 | 2015-04-02IRAK inhibitors and uses thereof
#65 | 2015-01-22IRAK inhibitors and uses thereof
#66 | 2014-08-07Deuterated 2-amino-3-hydroxypropanoic acid derivatives
#67 | 2014-07-10IRAK inhibitors and uses thereof
#68 | 2014-06-05Tetrahydronaphthalene derivatives
#69 | 2014-01-16PYRIMIDINE DERIVATIVES
#70 | 2014-01-16IRAK INHIBITORS AND USES THEREOF
#71 | 2014-01-16IRAK inhibitors and uses thereof
#72 | 2014-01-02Derivatives of pyrazole-substituted amino-heteroaryl compounds
#73 | 2013-10-24SYNTHESIS OF DEUTERATED MORPHOLINE DERIVATIVES
#74 | 2013-09-05IRAK inhibitors and uses thereof
#75 | 2013-05-23Analogues of cilostazol
#76 | 2013-05-16ACC inhibitors and uses thereof
#77 | 2013-01-03Substituted Diphenylpyrazine Derivatives
#78 | 2012-11-22Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
#79 | 2012-11-08IRAK inhibitors and uses thereof
#80 | 2012-10-25PROSTACYCLIN DERIVATIVES
#81 | 2012-09-27Peptides for the Treatment of HCV Infections
#82 | 2012-05-17Tetrahydronaphthalene derivatives
#83 | 2011-11-17Substituted oxazolidinone derivatives
#84 | 2011-10-20Derivatives of dimethylcurcumin
#85 | 2011-10-13Deuterated 2-amino-3-hydroxypropanoic acid derivatives
#86 | 2011-09-29Tetrahydronaphthalene derivatives
#87 | 2011-08-18Xanthenone-4-Acetic Acid Derivatives
#88 | 2010-12-02HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES
#89 | 2010-09-30Analogues of cilostazol
#90 | 2010-09-02Beta-Secretase modulators and methods of use
#91 | 2010-06-24Synthesis of deuterated morpholine derivatives
#92 | 2010-06-03NOVEL TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLES
#93 | 2009-10-29QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT
#94 | 2009-07-09Compounds and methods of use
#95 | 2009-05-28Substituted oxazolidinone derivatives
#96 | 2009-04-23Deuterated etravirine
#97 | 2007-08-09Beta-secretase modulators and methods of use
#98 | 2007-03-29Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitors
#99 | 2007-03-08Aryl nitrogen-containing bicyclic compounds and methods of use
#100 | 2006-10-26Compounds and methods of use
14017 ⎘